Delivery Order SPE2DB22D9316-SPE2DB25FYM51

Award Date 10/31/24
Potential Completion Date 11/22/24
Potential Value $6.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $5,634.90, is for the supply of 4,565,752,490 doses of the YF-VAX 1 vaccine. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group worth up to $499,999,999, which runs through December 31, 2025. The IDC allows...
The U.S. government agency, the Defense Logistics Agency (DLA), awarded a firm fixed-price delivery order contract worth $1,126.98 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of the YF-VAX 1 dose vaccine vials, with a period of performance through October 23, 2024. This delivery order contract is part of a larger, single-award indefinite delivery contract (IDC) the DLA has with DMS...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,772.79 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of a single dose of the YF-VAX vaccine, with a completion date of August 16, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) worth up to $499,999,999 that DMS Pharmaceutical Group holds...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,126.98, is for the delivery of 4,565,563,472 doses of the YF-VAX 1 DOSE VIALS vaccine. The order has a completion date of September 12, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,126.98 contract is for the supply of 4565263207 YF-VAX 1 dose vials, with a performance period ending on August 12, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
This is a $1,690.47 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for 4,565,058,724 doses of the YF-VAX vaccine, with a completion date of June 24, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, running through December...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,566,512,925 doses of the YF-VAX vaccine, with a ceiling value of $11,269.80 and a completion date of December 10, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $32,501.15 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of YF-VAX, a 1 dose vial vaccine, with a period of performance through August 8, 2024. This award is part of DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $28,174.50, is for the delivery of 4565353532 units of the YF-VAX 1 dose vaccine. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group worth up to $499,999,999 through December 31, 2025, under the DLA's SPE2DB...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,817.45, is for the delivery of YF-VAX 1 dose vials and has an ultimate completion date of August 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999,...
  • SPE2DB22D9316
    Indefinite Delivery Contract
  • SPE2DB22D9316-SPE2DB25FYM51
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order valued at $6,761.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for the supply of 4,566,343,076 doses of the YF-VAX 1 vaccine, with a period of performance through November 22, 2024.

This award is associated with a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Generated 1/30/25, 9:03 AM